{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most prevalent known cause of autosomal dominant Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as autosomal dominant Parkinson's disease caused by mutations in the LRRK2 gene."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We used an enzyme coupled steady state GTPase assay and purified protein in solution to examine the impact of pathogenic mutations in the ROC (R1441C) and COR (Y1699C) domains on LRRK2 GTPase activity.",
          "judgment": "Yes",
          "reasoning": "The GTPase activity assay is a relevant and established method to study the functional impact of mutations in the LRRK2 gene, which is directly related to the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Proteins prepared in this way showed purity of >90% as shown in the Coomassie stained SDS-PAGE gels. For full-length protein we observed weak GTPase activity for wild type while activity measured for the Y1699C mutant was indistinguishable from background activity of the dysfunctional T1348N mutant.",
          "judgment": "Yes",
          "reasoning": "The assay included controls (wild type and dysfunctional T1348N mutant) and demonstrated purity and functionality, indicating valid experimental conditions.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The same pattern of lower GTPase activity was observed for the R1441C mutant, confirming previous findings based on isotopic GTPase assays.",
          "judgment": "Yes",
          "reasoning": "The use of known pathogenic mutants (R1441C) as controls strengthens the validity of the assay results for the Y1699C mutation.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Our data allow us to propose a scenario combining inter-and intra-molecular aspects: the Y1699C mutation, situated on the intra-molecular ROC:COR interface, strengthens the intra-molecular ROC:COR interaction, thereby weakening the local dimerization of LRRK2 at the ROC-COR domain tandem which results in a decrease of LRRK2 GTPase activity.",
          "judgment": "Yes",
          "reasoning": "The paper provides a detailed mechanistic explanation for the pathogenic effect of the Y1699C mutation, supported by experimental data.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The proportion of GTP bound LRRK2 was determined in the absence and presence of the competing nucleotides ATP, CTP, GDP or GTP. No significant differences in the GTP-binding affinity or specificity were observed between LRRK2 wt and LRRK2 Y1699C.",
          "judgment": "Yes",
          "reasoning": "The study includes a comprehensive analysis of the variant's effect on GTP-binding, providing additional evidence for its pathogenic impact.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The Y1699C mutation in the LRRK2 gene demonstrates a significant reduction in GTPase activity, supported by controlled experiments and mechanistic insights, warranting a PS3_moderate strength rating for pathogenic evidence."
    }
  ]
}